AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

National HIV Testing Day, June 27, 2014

NIH logo

Transmission of HIV continues at an unacceptably high rate, and drug use plays an important role—both through exposure to infected body fluids among injection drug users and through the lowered inhibition and risky sexual behaviors that all forms of drug use facilitate. Almost 1.1 million Americans are currently living with the HIV virus, and nearly…

NIH Seeks Applications for HIV and Viral Hepatitis Co-Infection Research Funding

Ronald Valdiserri

The National Institutes of Health (NIH) recently released two funding opportunity announcements (FOAs) to support multidisciplinary studies of HIV and viral hepatitis co-infection. The opportunities were issued under NIH’s R01 or Research Project Grant program and R21 or Exploratory/Developmental Research Grant program. NIH notes that the FOAs were informed by priority areas in the Action…

NIDA 2014 Avant-Garde Award for HIV/AIDS Research

NIDA arp

This week, the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced the 2014 Avant-Garde Awards for HIV/AIDS research. According to a NIDA press release, the awards offer hope in battling HIV infection and improving long-term outcomes in HIV-infected drug users. With proposals ranging from enhancing the immune system’s ability…

HIV Vaccine Awareness Day

Dr. Anthony Fauci

Watch NIAID Director Anthony S. Fauci, M.D., discuss current HIV vaccine research approaches. Developing a safe and sufficiently effective HIV vaccine is essential if we are to achieve a timely and durable end to the global HIV/AIDS pandemic. The path to an HIV vaccine has not been—and will not be—an easy one. In the 27…

Updated Guidelines: Perinatal Antiretroviral Treatment

AIDS info logo

The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission announces the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. For a complete preview of key updates to the guidelines, please see What’s…

Conversations from CROI 2014: Dr. Douglas Dieterich on Important Advances in Hepatitis C

Doug Dietrich and Dr. Valdiserri

At the 2014 Conference on Retroviruses and Opportunistic Infections (CROI) , Dr. Ron Valdiserri sat down for an in-depth conversation with Dr. Doug Dieterich of the Icahn School of Medicine at Mount Sinai Hospital in New York, who made several presentations and was involved in scientific posters shared during the conference on hepatitis C mono-infection and…

Conversations from CROI 2014: Dr. Deborah Persaud Discusses Cases of Two HIV Positive Infants in Remission after Very Early Treatment

mg_persuad

Among the stories making headlines from the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston this week was the next chapter in the story of the Mississippi baby whose case Dr. Deborah Persaud shared at last year’s conference. This year, she and her colleagues shared an update on the status of that child…

NIH’s Dr. Carl Dieffenbach Shares Final Highlights from CROI 2014

BiAa_wdCQAAyw6e

As the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  drew to a close in Boston, Dr. Ron Valdiserri asked National Institutes of Health’s Dr. Carl Dieffenbach to share some final thoughts on highlights of the scientific advances presented there and how they will support efforts to improve outcomes along the HIV continuum of care. In…